title: Vitamin C intake and apoptosis in normal rectal epithelium.
abstract: Apoptosis, or programmed cell death, may lower the risk of neoplasia by removing genetically damaged or mutated cells. A high rate of apoptosis has been linked to a reduced risk of colorectal adenomas; therefore, it is important to understand factors that impact apoptosis. Antioxidants (e.g., vitamin C) protect cells from harmful oxidation processes but may interfere with apoptosis by protecting genetically damaged cells from reactive oxygen species-dependent cell death. The objective of this study was to evaluate the association between vitamin C intake and apoptosis in normal rectal mucosa. Study participants were part of a large, cross-sectional study, the Diet and Health Study III. Participants were recruited from consecutive, consenting patients who underwent colonoscopy at University of North Carolina Hospitals between August 1, 1998 and March 4, 2000. Vitamin C intake, obtained from a food frequency questionnaire, included both dietary sources and vitamin supplements. Apoptosis was measured by morphological evaluation of H&E-stained sections obtained from pinch biopsy samples of normal rectal mucosa in consenting participants (n = 503). The relationship between vitamin C and apoptosis varied by adenoma status. Among individuals with adenomas, there was an inverse linear association between apoptosis and total vitamin C intake. Similarly, individuals with adenomas in the highest quintile of total vitamin C intake were substantially less likely than those in the lowest quintile to have increased colonic apoptosis (odds ratio, 0.05; 95% confidence interval, 0.01-0.46). Vitamin C was not significantly associated with apoptosis in adenoma-free patients. High vitamin C intake was associated with reduced colorectal apoptosis among individuals with adenomas in this study population. Given that high apoptosis may lower colorectal cancer risk, vitamin C supplements may be contraindicated for patients with a history of adenomas.
authors.affiliation: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7555, USA. aconnell@e-mail.unc.edu
authors.forename: Alexandra E
authors.initials: AE
authors.lastname: Connelly
authors.forename: Jessie
authors.initials: J
authors.lastname: Satia-Abouta
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Martin
authors.forename: Temitope O
authors.initials: TO
authors.lastname: Keku
authors.forename: John T
authors.initials: JT
authors.lastname: Woosley
authors.forename: P Kay
authors.initials: PK
authors.lastname: Lund
authors.forename: Robert S
authors.initials: RS
authors.lastname: Sandler
mesh_terms: D000236:Adenoma / Q000178:diet therapy*; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage*; D017209:Apoptosis / Q000187:drug effects*; D001205:Ascorbic Acid / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000178:diet therapy*; D003430:Cross-Sectional Studies; D004435:Eating; D002149:Energy Intake; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009657:North Carolina; D012007:Rectum / Q000187:drug effects*; D013223:Statistics as Topic; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D001205:Ascorbic Acid